文献速递其他结缔组织病

儿童期起病干燥综合征成年期临床表型、分类及长期结局:单中心队列研究

Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study.
PubMed 文献 · Lancet Rheumatol · 2025-11-19

该单中心队列纳入30例儿童期起病干燥综合征患者并随访至成年,按Florida评分系统映射起病时临床表型,按Newcastle分层工具分层。发现两种疾病活动度和症状轨迹,诊断延迟超过3年与报告干燥症状患病率增加相关,13%发生淋巴瘤,57%累积损伤。

要点

  • 儿童期起病干燥综合征起病常见表现为疲劳、关节痛、干燥、腺体肿胀和皮疹。
  • 存在高与低ESSDAI及ESSPRI两种轨迹,损伤累积不因轨迹不同而异。

核心结论

  • 儿童期起病干燥综合征成年期呈现不同的疾病和症状轨迹,较高比例患者在成年早期发生损伤。

研究设计与样本

  • 单中心回顾性与前瞻性结合的队列分析,纳入英国伦敦大学学院医院青少年和年轻成人风湿病服务中心13-36岁儿童期起病干燥综合征患者30例。
  • 起病时按Florida评分系统映射临床表型,末次评估时按Newcastle干燥综合征分层工具分层。
  • 采用ESSDAI、ESSPRI和SSDDI分别评估疾病活动度、症状严重度和损伤轨迹。

主要发现

  • 起病最常见表现为疲劳22/30(73%)、关节痛21/30(70%)、干燥17/30(57%)、腺体肿胀15/30(50%)、皮疹10/30(30%)。

关键数值与推荐

  • 起病时按Florida评分系统定义临床表型,末次评估按Newcastle干燥综合征分层工具分层。
  • 疾病活动度用ESSDAI评估,症状严重度用ESSPRI评估,损伤用SSDDI评估。

临床怎么用

  • 原文未报告临床实践推荐。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Childhood-onset Sjögren's disease is a rare and under-investigated rheumatic condition. The natural course of childhood-onset Sjögren's disease in adulthood in not known. This study aimed to evaluate long-term disease trajectories and complications of childhood-onset Sjögren's disease and explore management strategies. METHODS: This combined retrospective and prospective analysis of a childhood-onset Sjögren's disease cohort with long-term follow-up into adulthood was done in individuals aged 13-36 years with childhood-onset Sjögren's disease recruited from a single tertiary adolescent and young adult rheumatology service at University College London Hospital, UK. Participants were either approached consecutively during routine clinical appointments, or their data were collected retrospectively from the time of diagnosis to the time of transition to the service, and prospectively thereafter. We mapped the cohort onto clinical phenotypes defined by the Florida Scoring System at disease onset and stratified them based on the Newcastle Sjögren's Stratification Tool at last assessment. Disease activity, symptom severity, and damage trajectories were assessed using European Alliance of Associations for Rheumatology (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), and Sjögren's Syndrome Disease Damage Index (SSDDI), respectively. People with related lived experience were involved in the study design and implementation. FINDINGS: Between March 1, 2020, and June 30, 2024, we identified 30 children and young people diagnosed with childhood-onset Sjögren's disease based on expert opinion. Mean age at onset was 12·7 years (SD 3·3). 28 (93%) of 30 individuals were female and two (7%) were male. The most common disease manifestations at onset were fatigue (22 [73%] of 30 individuals), arthralgia (21 [70%]), dryness (17 [57%]), glandular swelling (15 [50%]), and skin rashes (ten [30%]). Diagnostic delay of more than 3 years from symptoms onset increased the prevalence of reported dryness (nine [100%] of nine vs eight [38%] of 21; p=0·0014). Children and young people with childhood-onset Sjögren's disease had two distinct disease activity and symptom trajectories (high ESSDAI: mean 3·9 [SD 2·2] vs low ESSDAI: mean 0·8 [1·1]; p<0·0001 and high ESSPRI: mean 5·6 [2·7] vs low ESSPRI: mean 3·1 [1·0]; p=0·036), which could not be predicted by sex or age at onset, symptom duration, or duration of follow-up. Damage accrual did not differ based on activity and symptom trajectory (p=0·080 and p=1·0, respectively). At last review, the median ESSDAI score was 2·0 (IQR 2·0-8·0) and the ESSPRI score was 5·3 (3·0-7·0). Four (13%) of 30 patients developed lymphoma and 17 (57%) accumulated damage (SSDDI score ≥1). INTERPRETATION: This preliminary evaluation of long-term outcomes of childhood-onset Sjögren's disease in adulthood showed distinct patterns of disease and symptom trajectories and that a high proportion of children and young people develop damage in early adulthood. These findings highlight the need for improved research quality and evidence-based management strategies for better outcomes in this population. FUNDING: None.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Ciurtin C, Peng J, Taylor-Gotch R, et al. Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study. Lancet Rheumatol. 2025. PMID: 41274306. doi:10.1016/S2665-9913(25)00283-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。